Latest Australian Securities News

Sigma Healthcare has secured Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in reshaping Australia's pharmaceutical retail landscape.

AustChina Holdings Limited has had its trading suspension lifted following the disclosure of a material acquisition, signaling a pivotal moment for the investment firm.

Viridis Mining and Minerals Limited has been reinstated to ASX quotation following a capital raising announcement, ending its trading suspension and signaling renewed investor confidence.

Mako Gold Limited’s securities have been suspended from ASX trading following Aurum Resources’ dispatch of compulsory acquisition notices, signaling a pivotal ownership transition.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Dateline Resources Limited’s shares were suspended from ASX trading on 3 February 2025 due to a delayed periodic report, raising questions about compliance and future market activity.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Charter Hall Wholesale Management Limited has extended its off-market takeover offer for Hotel Property Investments, pushing the closing date to March 14, 2025. The offer is now unconditional, having cleared all defeating conditions.

Omnia Metals Group has identified promising gold, copper, nickel, and PGE anomalies at its Ord Basin Project, setting the stage for expanded exploration in 2025. The company also advances its Salt Creek Project with a Heritage Survey planned, while maintaining strong ESG and safety standards.

Golden Horse Minerals has successfully listed on the ASX, raising A$18 million to fund exploration across a consolidated 130km strike in Western Australia's Southern Cross Greenstone Belt. The company is gearing up for a major drilling campaign at the historic Hopes Hill gold mine.

ResMed Inc. has announced a quarterly ordinary dividend of USD 0.053 per share for holders of its ASX-listed Chess Depositary Instruments, with payments scheduled for March 2025.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.